STRATEGIES FOR MANAGING OTOLOGIC DISEASE
From Stanford University School of Medicines Otology and Neurotology Update
Educational Objectives
| The goal of this program is to improve medical and surgical approaches to cholesteatoma, diseases of the external auditory
canal, and other otologic conditions. After hearing and assimilating this program, the clinician will be better able to:
|
 | Describe the growth pattern and pathophysiology of cholesteatomas.
|
 | Manage recurrent and residual cholesteatomas, as well as those complicated by concurrent otitis media.
|
 | Identify the best candidates for canal-wall-intact and canal-wall-down mastoidectomy.
|
 | Name the most common microorganisms and predisposing factors involved in otitis externa.
|
 | Explain why revision stapedectomy should be attempted only in low-risk patients.
|
Faculty Disclosure
In adherence to ACCME Standards for Commercial Support, Audio-Digest requires all faculty and members of the planning
committee to disclose relevant financial relationships within the past 12 months that might create any personal conflicts
of interest. Any identified conflicts were resolved to ensure that this educational activity promotes quality in health
care and not a proprietary business or commercial interest. For this program, Dr. Selesnick reported that he has a royalty
agreement with Medtronic Xomed. Drs. Jackler and Parnes and the planning committee reported nothing to disclose
Acknowlegements
This program was recorded at the Stanford Otology and Neurotology Update, held November 6-8, 2008, in Palo Alto,
CA, and sponsored by the Stanford University School of Medicine. The Audio-Digest Foundation thanks the speakers
and Stanford University School of Medicine for their cooperation in the production of this program.
Cholesteatomas: Surgery and Recidivism
Robert Jackler, MD, Sewall Professor and Chair, Department of OtolaryngologyHead and Neck Surgery, Stanford
University School of Medicine, Palo Alto, CA
| Varieties of recidivism: recurrence; residual disease
|
| Pathophysiology: begins at eardrum; eventually penetrates and sometimes fills mastoid; residual material rarely left in
mastoid; explore middle ear first; look further only if infectious disease of concern, or if area around semicircular canals
penetrated; oval window niche, posterior tympanic recesses (facial recess, sinus tympani) most likely locations
|
 | Growth pattern: posterior epitympanic cholesteatomas most common, followed by posterior mesotympanic and anterior
epitympanic
|
 | Posterior epitympanic: draws pouch in lateral to malleus head and incus body; carries it into mastoid through aditus ad
antrum
|
 | Posterior mesotympanic: presentation may be subtle; comes up under diaphragm in posterior middle ear, into epitympanum,
deep to ossicle heads, before penetrating mastoid; drilling down bridge may transmit vibratory energy into
inner ear; two crescentic recesses span from round window to oval window, separated by facial nerve into lateral and
medial side; sinus tympani may be shallow or deep to facial nerve; can be hard to reach; often not visible on endoscopy,
but good management critical for avoiding residual cholesteatoma; facial recess approachwhen used for
cholesteatoma in lateral recess, can augment pneumatization pathway between middle ear and mastoid; diamond
burr facilitates procedure; tympanic annulus usually closest structure; best approach to orient to incus, view lateral
canal, and start drilling with diamond burr; find facial nerve and irrigate with gentle pressure; find stapes and chorda
tympani; exposure of round window usually not necessary; if incus eroded, remove bony bridge to create confluent
opening (enhances connection between middle ear and mastoid); important tipfacial nerve sits at base of ridge
behind stapes and round window; part of pyramidal process can be removed; no sinus tympani approach; cholesteatoma
can penetrate ventral to malleus head; canal-wall-down ear may harbor some residual material
|
| Role of laser: helpful when removing granulation tissue from around stapes; when cholesteatoma wraps around stapes,
speaker first removes as much as possible mechanically; scraping last remnant from stapes may result in hearing loss and
tinnitus; laser can remove final bits with no vibratory energy; sometimes arch remains intact, with cholesteatoma meeting
in obturator foramen and wrapping around footplate; speaker dissects arch with laser (involves some vibratory trauma);
leaves anterior arch high as basis for prosthesis; intact chain with severely medially rotated umbo stuck to medial
walluse laser to foreshorten back several millimeters for better graft placement; intact chain with cholesteatoma engulfing
malleus head and incus bodyexplore middle ear early to determine whether erosion present; use laser to remove
long process if still present (place small amount of Gelfoam, since overshoot of concern)
|
| Congenital cholesteatoma: detach drum from malleus for better view of anterior cholesteatoma; after cutting, difficult
to reattach drum to tip of umbo; use of laser facilitates reattachment
|
| Recurrent cholesteatoma: speaker usually leaves canal wall intact unless ear highly hypopneumatic; other indications
include good epitympanic support, reliable or pediatric patient, and healthy opposite ear; canal wall taken down in 60% to
70% of cases; associated with low recurrence rate; hearing results same, whether wall left intact or taken down; speaker
places full cartilage shields in ears at high risk for retraction; palisades techniquestrips of cartilage placed across eardrum;
indications for stagingconcern over residual disease in oval window, sinus tympani, or facial recess; mucosal
factors (bare or sparsely lined promontory); hemostasis recommended to stop bleeding; speaker uses monopolar cautery;
use of Bovie keeps area dry and facilitates microsurgery
|
Cholesteatoma with Chronic Otitis Media
Lorne Parnes, MD, Associate Professor and Chief, Department of Otolaryngology, University of Western Ontario
School of Medicine, London, ON
| Components of cholesteatoma: cystic contentkeratin debris; matrixepithelial lining; perimatrix
granulation tissue in contact with bone; produces proteolytic enzymes that erode bone; natural history is progressive
growth and bone destruction; may be congenital or acquired
|
| Pathogenesis of acquired cholesteatoma: theories includeinvagination (poor eustachian tube function produces
negative middle-ear pressure and resulting retraction); basal cell hyperplasia; migration (cells enter middle ear through
marginal perforation); squamous metaplasia in middle ear and mastoid
|
| Management: medical (aural toilet, local care, good hygiene, follow-up); tympanostomy tubes for early retraction pockets
(not always effective)
|
 | Surgery: transcanal atticotomy; Bondy modified radical procedure; debate now concerns canal-wall-down vs intact-wall
mastoidectomy; priorities are safe, dry hearing ear
|
 | Realities of Canadian health care system: advantagesequal access to treatment; single payor; less fear of malpractice
lawsuits; disadvantagescompetition for scarce resources, eg, computed tomography, (CT), magnetic resonance imaging
(MRI); patients often wait 12 mo for elective chronic ear surgery; influences speakers management of chronic
ear
|
 | Intact-canal-wall procedure: goals are to preserve wall, and make more natural, self-cleaning ear that can be exposed to
water; contraindicationsonly-hearing ear; labyrinthine fistula; requires second staged procedure (additional 6-12
mo wait in Canada); associated with high incidence of recidivism; as result, almost all of speakers cases are canal-
wall-down procedures
|
| Key points: goal is safe, dry, hearing ear; practice; know anatomy and attend temporal bone laboratory; what you do in
practice is what you do in the game; always obtain preoperative CT, read it yourself, and have it in operating room; use
facial nerve as key landmark; when taking canal wall down, lower facial ridge and perform generous meatoplasty (both
ensure well-aerated mastoid cavity); remain flexible, and expect the unexpected; follow patients for life
|
Diseases of the External Auditory Canal
Samuel Selesnick, MD, Professor and Vice Chair, Department of Otorhinolaryngology, Weill-Cornell Medical College,
and Attending Otorhinolaryngologist, New York-Presbyterian Hospital, New York, NY
| Anatomy: medial two-thirds bone; outer third is cartilage, site of external canal appendages, including apopilosebaceous
(cerumen-producing) units
|
 | Cerumen: bacteriostatic; hydrophobic barrier with acid cloak (normal pH of canal acidic); also contains immunoglobulins
and lysozyme
|
 | Natural protection of middle, inner ear: anterior canal overhang at temporomandibular joint; tragus, antitragus; hair at
verge can capture microscopic particles before they enter external auditory canal (EAC)
|
 | Proinflammatory stage: loss of cerumen, violation of skin
|
 | Inflammatory stage: characterized by itch-scratch cycle (inoculation, leading to accumulation of debris; patient attempts to
clean, scratching EAC, and leading to further inoculation)
|
 | Diagnosis: pain; erythema and edema in EAC; tenderness of EAC and tragus; absence of cerumen; otorrhea (may elicit
scratching); thickening of EAC
|
 | Microbiology: in industry-sponsored study of >2000 ears, Pseudomonas aeruginosa most common, followed by Staphylococcus
aureus and others; otomycosisfungi found in 1.7% of patients (incidence higher in hot humid locations);
Aspergillus nigermost common and resistant to usual topical treatments
|
 | Predisposing factors: use of cotton-tipped applicators; heat and humidity; skin maceration (leads to removal of cerumen,
saturation of stratum corneum, intercellular edema, and occlusion of cerumen glands, leading to stasis); psoriasis;
chronic dermatitis; history of radiation therapy; systemic illnesses (eg, diabetes); allergies
|
 | Management: clear debris frequently (microscope helpful); maintain pH of 3 to 4 with boric acid powder and/or acidic
drops; drops often contain acid, antimicrobial agent, and steroid; antibioticsPseudomonas resistant to neomycin;
Staphylococcus may be resistant to polymyxin; allergic reactions to neomycin common; quinolones (eg, ciprofloxacin
and dexamethasone [Ciprodex], ofloxacin [Floxin Otic]) provide good antimicrobial coverage with no ototoxicity; fungal
infectionstopical treatments include low pH agents and astringents toxic to fungi; topical antifungals have low
efficacy against Aspergillus but work for Candida (comprises only 20% of EAC pathogens); oral antifungals highly effective,
but hepatotoxic; caveatoral fluoroquinolones effective, but usually contraindicated in children (may damage
epiphyseal plates); management pearlshave patients avoid trauma and hot humid environments (use hair dryer
to dry ear; protect ears from water); apply topical steroids for dermatoses to prevent acute infection; follow irradiated patients
closely; eliminate allergens; appropriate topical medications; difficult casespatients who are immunosuppressed, infected
with HIV, noncompliant or infected with unusual pathogens
|
| Medial EAC fibrosis: most common etiologies chronic infection, surgery, and trauma; treatmentdilate and excise
plug; meatoplasty, and mastoidectomy if necessary; problem may recur unless tissue replaced with flaps or grafts
|
| EAC exostoses and osteomas: largest study conducted at House Ear Institute, Los Angeles, CA; 401 ears over 16
yr; indications for surgery include pain, recurrent otitis externa, significant conductive hearing loss, and recurrent
cerumen impaction; surgery consisted of postauricular approach, canal incisions as medially as exostoses allowed, lifting
skin off canal, burrowing into exostosis (keeping skin as intact as possible), and flicking off bony edge with
curette; replace with patients own ear skin, split thickness skin graft when necessary; some surgeons operate on posterior
wall at same time, but associated with higher risk for scar formation; transcanal osteotome technique also used,
but associated with higher risk for complications such as perforation of tympanic membrane
|
Stapes Surgery: Handling Challenging Cases
Dr. Jackler
| Mixed hearing loss: if patient will still need hearing aid after surgery, its not worth the risk
|
| Surgical pearls: speaker usually takes transcanal approach, but uses postauricular approach for closure <5.5 mm; scissors
recommended for cutting vascular strip; never accept limited exposure; strive for unhindered view of oval window
and good view of facial nerve and junction of pyramid and tendon
|
| Footplate variants: 2 main types are heavily fixed (obliterative) and lightly fixed (biscuit); biscuitsmall flange underneath
that hooks footplate in; blood pools peripherally; obliterativemore common; blood pools centrally
|
 | Procedure: obliterativethin footplate by drilling, then open in usual way; biscuitdrilling mobilizes flange (impairs
hearing); speaker drills on promontory side and log-rolls it; drill away promontory overhang if present; drill away
small remaining edge for unhindered view
|
| Facial nerve dehiscence: some facial nerves completely covered, but many have small opening on undersurface; do not
place hook or reflect laser into opening; overhanging facial nerve may create pseudo-otosclerosis and cause conductive
hearing loss; manage with hearing aid; if nerve narrows niche and overhangs, push it back with wire 0.5 mm longer than
nerve, or with prosthesis; facial palsyoccurs (rarely) 7 to 10 days after surgery; some experts recommend acyclovir
(speaker does not); may be transient
|
| Mass pushing on stapes: do not biopsy; may be facial nerve schwannoma pushing on stapes arch; obtain image before
proceeding
|
| Incus problems: deficient long processspeaker creates groove with microdrill; sets wire in groove and attaches it to
prosthesis; dislocated incusif loose, replace it, let it reattach, and reschedule surgery; no useful incusperform
malleus-down technique; challenging (must raise pocket around umbo); difficult to measure accurately; put bend in long
prosthesis and swing it down toward oval window, gradually straightening bend until correct angle achieved; persistent
stapedial arteryprescribe hearing aid
|
| Vestibular problems: endolymphatic hydropsfluctuating, low-frequency hearing loss or vertigo; do not open oval
window (swollen endolymphatic system increases risk); speaker makes opening with microdrill; use 24-gauge needle suction,
thumb off hole; avoid fenestra vestibuli; do not penetrate plane; 45-mm hook essential; leave fragments that drop in
oval window (speaker leaves mucosa on footplate); if laser does not work on stapes footplate surface, could be that footplate
reflecting energy to undersurface of facial nerve (possibly resulting in facial nerve palsy), or elsewhere; induce minor bleeding
so blood can absorb laser energy; speaker uses membrane only on large fenestra; perilymph fistulaerare; when removed,
round window grows back; if fistula present, create iatrogenic hemotympanum to promote healing
|
| Revision stapes surgery: speaker not in favor of early re-exploration; margination of wire important; avoid bony reclosure
of window; redrilling raises risk for sensory loss; speaker revises cases only if risk relatively modest; examples
of low-risk casesremoving adhesions with laser; tightening loose wire; medium-risk casesmarginalized prosthesis
and big fenestra; popped piston with thin membrane (speaker removes prosthesis and opens fenestra slightly);
high-risk casesremoving long prostheses; redrilling bony window; patients with significant sensory loss
|
 | Anesthesia: speaker prefers local anesthesia for revisions; can get patient responses to wire movement
|
 | Informed consent: 90% better in primary surgery (1% deafness); in all comers, hearing improves after revision in 50%
of patients and incidence of deafness 4%; justifies selection of lower-risk cases
|
 | Early postoperative sensory hearing loss: takes 4 to 6 wk for hearing to stabilize after stapedectomy; better not to perform
hearing test too soon after procedure
|
 | Postoperative vertigo: usually resolves spontaneously
|
 | Pseudoconductive hearing loss: may signal canal dehiscence; intact reflexes clue that hearing loss not caused by otosclerosis;
if hearing loss present since childhood, rule out malformation with CT; disruption of cochlear-vestibular malformation may
induce leakage of cerebrospinal fluid (CSF; only first 30 µL is perilymph); managing CSF leakput patient in Trendelenburg
position; let fluid drain out; then put patient in reverse Trendelenburg position, and apply tissue sealant; stapedectomy
contraindicated for abnormal inner ear
|
 | Suggested Reading
| Bauchet St Martin M et al: High-frequency sensorineural hearing loss after stapedectomy. Otol Neurotol 29:447,
2008; House JW, Wilkinson EP: External auditory exostoses: evaluation and treatment. Otolaryngol Head Neck
Surg 138:672, 2008; Makarem A, Linthicum FH: Cochlear otosclerosis and endolymph hydrops. Otol Neurotol
29:571, 2008; Massey BL et al: Stapedectomy in congenital stapes fixation: are hearing outcomes poorer? Otolaryngol
Head Neck Surg 134:816, 2006; Rinaldo A et al: Immediate facial nerve palsy following stapedectomy. ORL J
Otorhinolaryngol Related Spec 64:355, 2002; Roland PS, Stroman DW: Microbiology of acute otitis externa.
Laryngoscope 112:1166, 2002; Rosenfeld RM et al: Clinical practice guideline: acute otitis externa. Otolaryngol
Head Neck Surg 134:S4, 2006; Rosenfeld RM et al: Systematic review of topical antimicrobial therapy for acute
otitis externa. Otolaryngol Head Neck Surg 134:S24, 2006; Salvinelli F et al: Delayed peripheral facial palsy in the
stapes surgery: can it be prevented? Am J Otolaryngol 25:105, 2004; Sanna M et al: Canalplasty for severe external
auditory meatus exostoses. J Laryngol Otol 118:607, 204; Selesnick S et al: Surgical treatment of acquired external
auditory canal atresia. Am J Otol 19:123, 1998.
|